Table 3 Regional systolic strain (RegLS) from each LV segment at the post-treatment (8 months) in each group.
LV segment | Control | Chagas | Ch + BB | Ch + ACEi | p (ANOVA) |
|---|---|---|---|---|---|
Post_base | − 12.22 ± 4.99 | − 8.80 ± 3.80 | − 11.13 ± 4.07 | − 9.70 ± 4.50 | 0.3 |
Post_med | − 11.80 ± 4.64 | − 7.34 ± 3.75* | − 8.45 ± 3.24* | − 7.69 ± 3.60* | 0.03 |
Post_apex | − 17.31 ± 6.89 | − 11.07 ± 3,78* | − 10.83 ± 5.67* | − 10.95 ± 5.92* | 0.03 |
Ant_base | − 14.46 ± 4.55 | − 14.75 ± 4,84 | − 12.95 ± 5.31 | − 11.46 ± 4.28 | 0.2 |
Ant_mid | − 11.46 ± 7.10 | − 1136 ± 2,09 | − 9.49 ± 3.14 | − 9.56 ± 4.49 | 0.6 |
Ant_apex | − 14.05 ± 7.00 | − 6.88 ± 4.44* | − 9.82 ± 2.92* | − 8.03 ± 3.83* | 0.01 |